Igama elijwayelekile: | I-Semaglutide |
Inombolo yeCas: | 910463-68-2 |
I-Molecular Formula: | I-C187H291N45O59 |
Isisindo samangqamuzana: | 4113.641 g/mol |
Ukulandelana: | -His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17 -carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH |
Ukubukeka: | Impushana emhlophe |
Isicelo: | I-Semaglutide umuthi osetshenziselwa ukwelapha isifo sikashukela sohlobo 2. Kungokwesigaba sezidakamizwa ezibizwa ngokuthi ama-GLP-1 receptor agonists, asebenza ngokwandisa ukukhiqizwa kwe-insulin nokunciphisa ukukhiqizwa kwe-glucose esibindini. I-Semaglutide ijojowe kanye ngesonto futhi iboniswe ezivivinyweni zomtholampilo ukuze inciphise ngempumelelo amazinga kashukela egazini. Ukwengeza, kuye kwahlotshaniswa nokulahlekelwa isisindo kanye nemiphumela ethuthukisiwe yenhliziyo. I-Semaglutide ivame ukubekezelelwa kahle, kodwa ezinye iziguli zingase zibe nemiphumela emibi efana nesicanucanu, ukuhlanza noma isifo sohudo. Iziguli kufanele zixoxe ngayo yonke imiphumela emibi engaba khona kanye nezingozi nomhlinzeki wazo wezempilo ngaphambi kokuthatha i-semaglutide. Kubalulekile ukuqaphela ukuthi i-semaglutide akufanele isetshenziselwe ukwelapha uhlobo lwe-1 yesifo sikashukela noma i-ketoacidosis yesifo sikashukela. |
Iphakheji: | isikhwama se-aluminium foil noma i-aluminium TIN noma ngokwezidingo zekhasimende ngalinye |
1 | Umhlinzeki oqeqeshiwe wama-API we-peptide ovela e-China. |
2 | Imigqa yokukhiqiza engu-16 enamandla okukhiqiza amakhulu anenani elincintisanayo |
3 | I-GMP ne-DMF itholakala ngemibhalo enokwethenjelwa kakhulu. |
A: Yebo, singapakisha njengemfuneko yakho.
A: I-LC sight kanye ne-TT esikhathini sokukhokha kusengaphambili esikhethwayo.
IMP: Yebo, sicela unikeze ukucaciswa kwekhwalithi yakho, sizohlola i-R&D yethu futhi sizame ukufanisa ukucaciswa kwekhwalithi yakho.